secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001641172-25-015612
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed shareholders re-elect directors, approve equity plan increase and stock issuance at annual meeting
--------------------------------------------------------------------------------

- Re-elected Lishan Aklog (7.15M for, 2.08M withheld) and Michael Glennon (7.22M for, 2.01M withheld) as Class C directors.
- Approved issuance of common stock upon exercise of pre-funded warrants from Feb 2025 private placement (4.65M for, 0.29M against).
- Approved amendment to 2014 equity plan increasing authorized shares by 2.5M, from 2,412,140 to 4,912,140 shares.
- Advisory say-on-pay passed with 7.11M for, 0.38M against; ratification of Marcum LLP as auditor for 2025 passed with 14.22M for.
- Turnout was ~77.2% of outstanding shares entitled to vote (common + preferred as-converted).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000164117225015612/0001641172-25-015612-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000164117225015612/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-015612

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer